Examining the Sudan virus epidemic in Uganda via the use of a mobile laboratory - Takeaways - MDSpire

Examining the Sudan virus epidemic in Uganda via the use of a mobile laboratory

  • By

  • Godfrey Pimundu

  • Tonny Muyigi

  • Eunice Jennifer Nambozo

  • Christopher Okiira

  • Benedict Kanamwanji

  • Rebecca Nalwanga

  • Joseph Sekate

  • Raymond Mugabe

  • Juliet Naiga

  • Isaac Sewanyana

  • Julius Lutwama

  • Stephen Balinandi

  • Pontiano Kaleebu

  • Jane Ruth Aceng

  • Diana Atwiine

  • Henry Mwebesa

  • Henry Kyobe Bosa

  • Atek Kagirita

  • Charles Olaro

  • Andrew Nsawotebba

  • Emmanuel Achol

  • Hakim Lagu

  • Eric Nzeyimana

  • Juergen May

  • Florian Gehre

  • Muna Affara

  • Susan Nabadda

  • January 16, 2026

  • 0 min

Share

  • 1

    Ebola disease is caused by viruses in the Filoviridae family, with Sudan virus being one of the identified species affecting humans.

  • 2

    Uganda has experienced multiple Ebola outbreaks, with the first occurring in 2000, primarily caused by Sudan virus and Bundibugyo virus.

  • 3

    In September 2022, Uganda declared its sixth Ebola outbreak, caused by Sudan virus, prompting the deployment of a mobile laboratory for rapid diagnostics.

  • 4

    The mobile laboratory, positioned next to the Ebola Treatment Unit, aimed to reduce turnaround time for laboratory diagnostics during the outbreak.

  • 5

    The mobile laboratory processed an average of 25 samples daily, operated by a trained team to ensure continuous diagnosis and support outbreak containment efforts.

Original Source(s)

Examining the Sudan virus epidemic in Uganda via the use of a mobile laboratory

  • by Godfrey Pimundu, Tonny Muyigi, Eunice Jennifer Nambozo, Christopher Okiira, Benedict Kanamwanji, Rebecca Nalwanga, Joseph Sekate, Raymond Mugabe, Juliet Naiga, Isaac Sewanyana, Julius Lutwama, Stephen Balinandi, Pontiano Kaleebu, Jane Ruth Aceng, Diana Atwiine, Henry Mwebesa, Henry Kyobe Bosa, Atek Kagirita, Charles Olaro, Andrew Nsawotebba, Emmanuel Achol, Hakim Lagu, Eric Nzeyimana, Juergen May, Florian Gehre, Muna Affara, Susan Nabadda

  • January 16, 2026

Related Content

Varicella Pneumonia Requires IV Acyclovir

Case highlights need for early intravenous antiviral treatment in adults with rash and hypoxia

FDA Expands ASCENIV Pediatric Use

Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.

The hantavirus is a wake-up call. Will the Trump administration answer it?